Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq

Abstract

BackgroundMast cells, comprising a crucial component of the tumor immune milieu, modulate neoplastic progression by secreting an array of pro- and antitumorigenic factors. Numerous extant studies have produced conflicting conclusions regarding the impact of mast cells on the prognosis of patients afflicted with lung adenocarcinoma (LUAD).MethodsEmploying single-cell RNA sequencing (scRNA-seq) analysis, mast cell-specific marker genes in LUAD were ascertained. Subsequently, a mast cell-related genes (MRGs) signature was devised to stratify LUAD patients into high- and low-risk cohorts based on the median risk value. Further investigations were conducted to assess the influence of distinct risk categories on the tumor microenvironment. The prognostic import and capacity to prognosticate immunotherapy benefits of the MRGs signature were corroborated using four external cohorts. Ultimately, the functional roles of SYAP1 were validated through in vitro experimentation.ResultsAfter scRNA-seq and bulk RNA-seq data analysis, we established a prognostic signature consisting of nine MRGs. This profile effectively distinguished favorable survival outcomes in both the training and validation cohorts. In addition, we identified the low-risk group as a population more effective for immunotherapy. In cellular experiments, we found that silencing SYAP1 significantly reduced the proliferation, invasion and migratory capacity of LUAD cells while increasing apoptosis.ConclusionOur MRGs signature offers valuable insights into the involvement of mast cells in determining the prognosis of LUAD and may prove instrumental as a navigational aid for immunotherapy selection, as well as a predictor of immunotherapy response in LUAD patients.

Clinical prognostication and immunotherapy response prediction in esophageal squamous cell carcinoma using the DNA damage repair‐associated signature

“…In the scRNA‐seq analysis, the raw data was transformed into a Seurat object using the Seurat R package 17,18 (version 4.2.0). Stringent quality control measures were implemented during data preprocessing.…”

Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy

“…In single-cell RNA sequencing analysis, we utilized the Seurat R package ( 15 , 16 ) (version 4.2.0) to transform the raw data into a Seurat object. During the data preprocessing, we implemented stringent quality control measures.…”

Unveiling the role of regulatory T cells in the tumor microenvironment of pancreatic cancer through single-cell transcriptomics and in vitro experiments

“…Subsequent studies have further substantiated this finding, demonstrating that Treg cells are the most potent immunosuppressants known to dampen the activity of CD4+, CD8+, and NK cells ( 27 ). The immunosuppressive mechanisms mediated by Treg cells include the direct elimination of effector T cells and competition with effector T cells for antigen-presenting cells ( 28 , 29 ). Therefore, understanding the secrets of the pancreatic cancer tumor microenvironment, particularly the role of Treg cells in pancreatic cancer, holds significant importance.…”